Stable transport of cancer drugs

Stable transport of cancer drugs

Cytostatics, also known as chemotherapeutic agents, are used in the treatment of cancer. Due to their mechanism of action—inhibiting or destroying the growth of cancer cells—they are classified as hazardous drugs. It is not common knowledge that cytostatics can enter the bodies of medical personnel during the process of preparing, mixing, and administering these substances. Therefore, proper procedures must be followed when handling these drugs, which is extremely important at every stage of contact with cytostatics. So, what does the transport of a potentially hazardous cargo essential for oncological treatment look like?

Cytostatics are toxic substances and can cause harmful effects in both patients and those who work with them. They enter the body through inhalation, contact with skin and mucous membranes, and through contamination of clothing and the environment. The supplier’s main duty is, first and foremost, to minimize risk. The transport of cytostatic drugs requires special precautions due to their potential threat to human health and the environment. Cytostatics must be delivered in separate, non-returnable packaging, carefully secured during transport to prevent the drugs from leaking out. Equally important, and indeed crucial, is the protection of the drugs’ properties. In the case of cytostatics, one must speak of above-average patient expectations in this regard. The challenge lies in minimizing the transit time of these drugs and meticulously maintaining controlled conditions.

– Service timeliness can and should be measured among one’s subcontractors and logistics partners. For example, Pharmalink achieved an OTiF rate of 99.6% for on-time pharmaceutical deliveries. This is the result of the work of an entire specialized team, but also of a properly planned infrastructure – says Anna Gałecka, a Pharmalink expert responsible for overseeing the trade of narcotic drugs, psychotropic substances, or precursors. – To be able to ensure “just in time” deliveries, our company has an extensive infrastructure throughout Poland. We have a Central Cross-Docking Chamber (CKP) in Konstantynów Łódzki and a system of seven cross-docks across the country, which means that the effective execution of logistics processes within 24 hours and in “cito” mode within 6 hours is possible for us – the expert adds.

High-risk cargo

Packaging containing cytostatics should be properly labeled to indicate their potential hazard. It is advisable to place special labels on the packaging informing about the content of cytostatic substances and the need for caution when handling them. An absolute requirement is clear labeling in the form of black text on a yellow background: “CAUTION! CYTOSTATIC DRUGS”. An additional warning is a separately issued invoice with the same annotation. Importantly, the pharmaceutical company is primarily responsible for securing the drug and providing information on its use. Receiving such a product into a hospital pharmacy should be done using disposable protective gloves. Both the gloves and the drug packaging are sent for disposal. In other words, it is difficult to imagine cytostatic drugs being transported by a logistics operator without pharmaceutical specialization. Another argument for this is temperature requirements. Anti-cancer preparations maintain full efficacy only if the appropriate temperature requirements are met under all circumstances; furthermore, they are light-sensitive.

Under full supervision

There is a lot of information available regarding how cytostatic drugs are prepared and stored within a hospital. Regulations and instructions are intended to protect medical personnel and patients from potential contamination. Those responsible for the transport of cytostatic drugs should also be properly trained in the proper handling of these substances and in following safety procedures. The transport of cytostatic drugs is subject to strict rules and regulations regarding chemical safety. What pharmaceutical logistics services ensure full supervision, and consequently, the safety and stability of the preparations?

  1. Drug transport. Logistics operators specializing in pharmaceutical distribution transport only drugs, medical devices, dietary supplements, and other medical assortments, which allows them to ensure the highest standard of hygiene and safety compliance for every cargo—biological, toxic, or radioactive.
  2. Controlled conditions. Thanks to a specialized fleet and additional equipment (dual-chamber vehicles, portable refrigerators), pharmaceutical carriers are able to meet the standards required by the drug manufacturer throughout the entire distribution route, at any time of the year. The vehicles not only have isothermal bodies and heating/cooling devices, but are also mapped, and the temperature inside the vehicle’s cargo hold is constantly monitored.
  3. Delivery with a report. Real-time monitoring allows for the ongoing control and correction of the cargo temperature. The driver, in cooperation with the Temperature Department, reacts to every alarm signal regarding changes in temperature conditions in the vehicle’s cargo hold, taking corrective actions. Finally, all events are reflected in a report presented to the Recipient along with the delivered cargo. Based on this, the hospital, pharmacy, or pharmaceutical wholesaler can assess whether the delivered products meet quality requirements.
  4. Protection against theft and unauthorized access. Due to the potential health risk, cytostatic drugs should be transported in a way that ensures their security against theft and access by unauthorized persons. Properly qualified vehicles, equipped with security features such as central locking, alarms, or key locks, and the drivers’ awareness of the value of the transported goods are essential for securing the product, human health, and the environment. Those responsible for the transport of cytostatic drugs should be properly trained in the proper handling of these substances and in following safety procedures.

Cytostatic drugs, due to their properties, require precise supervision throughout the entire supply chain. Manufacturers, suppliers, and recipients are responsible for protecting the properties of the preparations, but also for the safety of every person who comes into contact with the product. Modern services provided by logistics operators for the pharmaceutical industry measurably support these types of processes.

Source: Pharmalink